Unknown

Dataset Information

0

Tolerogenic Dendritic Cells Induce Apoptosis-Independent T Cell Hyporesponsiveness of SARS-CoV-2-Specific T Cells in an Antigen-Specific Manner.


ABSTRACT: Although the global pandemic caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still ongoing, there are currently no specific and highly efficient drugs for COVID-19 available, particularly in severe cases. Recent findings demonstrate that severe COVID-19 disease that requires hospitalization is associated with the hyperactivation of CD4+ and CD8+ T cell subsets. In this study, we aimed to counteract this high inflammatory state by inducing T-cell hyporesponsiveness in a SARS-CoV-2-specific manner using tolerogenic dendritic cells (tolDC). In vitro-activated SARS-CoV-2-specific T cells were isolated and stimulated with SARS-CoV-2 peptide-loaded monocyte-derived tolDC or with SARS-CoV-2 peptide-loaded conventional (conv) DC. We demonstrate a significant decrease in the number of interferon (IFN)-γ spot-forming cells when SARS-CoV-2-specific T cells were stimulated with tolDC as compared to stimulation with convDC. Importantly, this IFN-γ downmodulation in SARS-CoV-2-specific T cells was antigen-specific, since T cells retain their capacity to respond to an unrelated antigen and are not mediated by T cell deletion. Altogether, we have demonstrated that SARS-CoV-2 peptide-pulsed tolDC induces SARS-CoV-2-specific T cell hyporesponsiveness in an antigen-specific manner as compared to stimulation with SARS-CoV-2-specific convDC. These observations underline the clinical potential of tolDC to correct the immunological imbalance in the critically ill.

SUBMITTER: Van Delen M 

PROVIDER: S-EPMC9740551 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Tolerogenic Dendritic Cells Induce Apoptosis-Independent T Cell Hyporesponsiveness of SARS-CoV-2-Specific T Cells in an Antigen-Specific Manner.

Van Delen Mats M   Janssens Ibo I   Dams Amber A   Roosens Laurence L   Ogunjimi Benson B   Berneman Zwi N ZN   Derdelinckx Judith J   Cools Nathalie N  

International journal of molecular sciences 20221202 23


Although the global pandemic caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still ongoing, there are currently no specific and highly efficient drugs for COVID-19 available, particularly in severe cases. Recent findings demonstrate that severe COVID-19 disease that requires hospitalization is associated with the hyperactivation of CD4<sup>+</sup> and CD8<sup>+</sup> T cell subsets. In this study, we aimed to counteract this high inflammatory state by inducing  ...[more]

Similar Datasets

| S-EPMC3008555 | biostudies-literature
| S-EPMC3283565 | biostudies-literature
| S-EPMC4210310 | biostudies-literature
| S-EPMC7856150 | biostudies-literature
| S-EPMC9728525 | biostudies-literature
| S-EPMC5719080 | biostudies-literature
| S-EPMC6156403 | biostudies-literature
| S-EPMC5840162 | biostudies-literature
| S-EPMC4603940 | biostudies-literature
| S-EPMC3564474 | biostudies-literature